| scholarly article | Q13442814 |
| P50 | author | Heather Skirton | Q42416963 |
| Lyn S Chitty | Q56526261 | ||
| P2093 | author name string | Celine Lewis | |
| Melissa Hill | |||
| P2860 | cites work | Development of a measure of informed choice suitable for use in low literacy populations | Q56786163 |
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Informed choice in antenatal Down syndrome screening: A cluster-randomised trial of combined versus separate visit testing | Q57278520 | ||
| Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices? | Q57278531 | ||
| Are pregnant women making informed choices about prenatal screening? | Q64904746 | ||
| Accepting or declining the offer of prenatal screening for congenital defects: test uptake and women's reasons | Q81301934 | ||
| Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy | Q85495453 | ||
| Update on Procedure-Related Risks for Prenatal Diagnosis Techniques | Q22241937 | ||
| ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities | Q22242787 | ||
| Ethnic differences in informed decision-making about prenatal screening for Down's syndrome | Q29353880 | ||
| What hinders minority ethnic access to cancer genetics services and what may help? | Q33765202 | ||
| The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). | Q34252950 | ||
| Non-invasive prenatal testing: ethical issues explored | Q34328617 | ||
| Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol | Q34480344 | ||
| Informed choice for screening: implications for evaluation | Q34601338 | ||
| Measuring informed choice in population-based reproductive genetic screening: a systematic review. | Q34705206 | ||
| Effect of evidence based risk information on "informed choice" in colorectal cancer screening: randomised controlled trial | Q35020252 | ||
| Impact on informed choice of offering antenatal sickle cell and thalassaemia screening in primary care: a randomized trial | Q35169984 | ||
| Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review | Q35857896 | ||
| A measure of informed choice. | Q37331258 | ||
| Exploring informed choice in the context of prenatal testing: findings from a qualitative study | Q37332377 | ||
| Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening | Q37333195 | ||
| Offering prenatal diagnostic tests: European guidelines for clinical practice [corrected]. | Q37711798 | ||
| Screening for fetal aneuploidies at 11 to 13 weeks | Q37826399 | ||
| Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. | Q38186934 | ||
| Women's uptake of non-invasive DNA testing following a high-risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review | Q38284800 | ||
| Non-invasive prenatal testing: UK genetic counselors' experiences and perspectives | Q39113200 | ||
| Deliberation before determination: the definition and evaluation of good decision making | Q39948568 | ||
| The multi-dimensional measure of informed choice: a validation study | Q40634859 | ||
| Genetic counselors' experience with cell-free fetal DNA testing as a prenatal screening option for aneuploidy | Q43570601 | ||
| Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011. | Q51866446 | ||
| Informed decision making in the context of prenatal screening. | Q51961401 | ||
| Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey. | Q51993722 | ||
| Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. | Q53364400 | ||
| Non-invasive prenatal testing for Down's syndrome: pregnant women's views and likely uptake | Q56773442 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 809-816 | |
| P577 | publication date | 2015-10-28 | |
| P1433 | published in | European Journal of Human Genetics | Q2155433 |
| P1476 | title | Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy | |
| P478 | volume | 24 |
| Q37316476 | A qualitative study looking at informed choice in the context of non-invasive prenatal testing for aneuploidy |
| Q39387768 | Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy |
| Q30847203 | Development and evaluation of training resources to prepare health professionals for counselling pregnant women about non-invasive prenatal testing for Down syndrome: a mixed methods study |
| Q89663531 | Does a web-based decision aid improve informed choice for fertility preservation in women with breast cancer (DECISIF)? Study protocol for a randomised controlled trial |
| Q54935969 | Facilitating autonomous, confident and satisfying choices: a mixed-method study of women's choice-making in prenatal screening for common aneuploidies. |
| Q61448634 | Facilitating informed choice about non-invasive prenatal testing (NIPT): a systematic review and qualitative meta-synthesis of women's experiences |
| Q48126001 | Informed choice and decision making in women offered cell-free DNA prenatal genetic screening. |
| Q57809529 | Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals |
| Q35977714 | NIPT and Informed Consent: an Assessment of Patient Understanding of a Negative NIPT Result |
| Q48094333 | Offering non-invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained? |
| Q53163552 | Patients' Knowledge of Prenatal Screening for Trisomy 21. |
| Q92664348 | Personalized Medicine Implementation with Non-traditional Data Sources: A Conceptual Framework and Survey of the Literature |
| Q97567990 | Pregnant women's attitudes and decision-making regarding prenatal Down syndrome screening and diagnosis: scale development and validation |
| Q38954748 | Prenatal and pre-implantation genetic diagnosis |
| Q52650298 | Talking Points: Women's Information Needs for Informed Decision-Making About Noninvasive Prenatal Testing for Down Syndrome. |
| Q46271940 | The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population |
| Q41640999 | The effect of a decision aid on informed decision-making in the era of non-invasive prenatal testing: a randomised controlled trial |
| Q37557986 | Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives |
| Q37067727 | Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units |
| Q48169164 | Views of the obstetric profession on non-invasive prenatal testing in Aotearoa New Zealand: A national survey |
| Q35979539 | Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study |
| Q52319943 | Women's perspectives on the ethical implications of non-invasive prenatal testing: a qualitative analysis to inform health policy decisions. |
Search more.